How many insider trades does FilingIQ track for TXMD?

FilingIQ tracks 301 Form 4 insider transactions for TXMD (TherapeuticsMD, Inc.), covering filings from Mar 25, 2015 onwards. 0 of those were filed in the last 90 days.

Are TXMD insiders net buyers or net sellers?

Across the full Form 4 history for TXMD, 55 transactions (18%) were open-market purchases and 76 (25%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does TXMD insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is TXMD in?

TherapeuticsMD, Inc. (TXMD) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $25.00M.

TXMD insider trading

NasdaqGS Healthcare

TherapeuticsMD, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

301

Last 90 days

Buys / sells

18% / 25%

Market cap

$25.00M

About TherapeuticsMD, Inc.

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Company website: www.therapeuticsmd.com

TXMD insider activity at a glance

FilingIQ has scored 301 insider transactions for TXMD since Mar 25, 2015. The most recent filing in our index is dated Dec 23, 2025.

Across the full history, 55 open-market purchases and 76 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on TXMD insider trades is 56.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live TXMD trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for TXMD?: FilingIQ tracks 301 Form 4 insider transactions for TXMD (TherapeuticsMD, Inc.), covering filings from Mar 25, 2015 onwards. 0 of those were filed in the last 90 days.
Are TXMD insiders net buyers or net sellers?: Across the full Form 4 history for TXMD, 55 transactions (18%) were open-market purchases and 76 (25%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does TXMD insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is TXMD in?: TherapeuticsMD, Inc. (TXMD) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $25.00M.

Methodology & sources

Every TXMD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.